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Iodoacetic acid (IAA) has been applied to different species to acutely induce photoreceptor degeneration. The purpose of the 
present study was to use this toxin to thoroughly eliminate photoreceptors and induce complete blindness in the cat. IAA was 
delivered by single ear vein injection (20 mg kg1). Six months after the IAA treatment, functional evaluations including pu-
pillary light reflex (PLR), electroretinogram (ERG), visual behavior tests were performed. Morphological examinations were 
carried out after the functional evaluation. The present result shows that, six months after the IAA application, animals lost 
visual functions and became completely blind. High dose IAA application via ear vein delivery created an acute and reliable 
complete photoreceptor degeneration model in the cat. This model can be applied to genetic and cellular therapies for visual 
function restoration. 
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Iodoacetic acid (IAA) inhibits anaerobic glycolysis by re-
acting with the sulfhydryl group of glyceraldehyde-3-      
phosphate dehydrogenase [1], resulting in lower production 
of metabolic energy that causes impaired visual function 
and photoreceptor death. IAA has been applied to different 
species to induce photoreceptor degeneration including rat 
[2], rabbit [3–8], Ground squirrel [9], cat and monkey [4]. 
However, at the same time the inner retina and central visu-
al system are well preserved, which is a similar case that 
could be found in retinitis pigmentosa (RP) and age related 
macular degenerations (AMD) of human. By intravenous 
delivery of IAA via ear vein, it has been demonstrated that 
IAA could quickly produce a massive photoreceptor deple-
tion in large mammals such as swine and results in severe 
visual impairment whereas retinal ganglion cells are spared 
[10,11].  
IAA induced retinal degeneration has been widely ap-
plied to various retinal disease animal models. Depending 
on the purpose of the experiments, the most of current ap-
plications are interested in inducing partial photoreceptor or 
pigment epithelium degeneration and create a certain retinal 
disease of given stage [2,3,7,10,12–14]. For photoreceptor 
degeneration, it is reported that after the treatment, rods 
were completely eliminated while cones were less affected 
[4]. Similar results were observed in rat [2]. Interestingly, 
the long lasting damage to the photoreceptors did not lead to 
a reorganization of the surviving cells, at least with survival 
as long as six months [7]. Nevertheless, the degree of IAA 
induced injury varies with the dosage and the same dosage 
of IAA induced photoreceptor degeneration varies among 
individual animals, occasionally different level of injury 
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observed between eyes of the same animal [7,10,14]. These 
differences clearly make it challenging to determine the 
extent of damage by IAA. To date, there is no large mam-
mal animal model available for the complete blindness that 
mimics the end stage retinal disease such as RP and AMD. 
We sought to develop an animal model of complete blind-
ness induced by intravenous injection of IAA in the feline.  
Here we report a newly developed feline model of acute 
and complete photoreceptor degeneration with only one 
intravenous injection of IAA. Six months after the IAA 
treatment a series of physiological, behavioral, and mor-
phological examinations were performed, and IAA treated 
animal demonstrated complete lost visual functions. Together, 
this model could offer an indispensable tool to evaluate the 
efficacy of various treatments for visual function restore.   
1  Methods 
1.1  Animals  
Young adult cats (2–3 years old) of either sex were used in 
this experiment. Cats were kept at 12 h/12 h light and dark 
environment. Food and water were provided ad libitum. All 
experiments were performed in accordance with Peking 
University guidelines for animal research and the ARVO 
Statement for the Use of Animals in Ophthalmic and Vision 
Research. The experimental animal protocol used in this 
study was approved by Peking University Institutional An-
imal Care and Use Committee (IACUC). Cats received an 
intravenous injection of 20 mg kg1 body weight of sterile 
(PH balanced) IAA (Sigma Chemical Corp., St Louis, MO, 
USA).  
1.2  Pupillary light reflex (PLR)  
PLR measurements of pupillary area were made as a func-
tion of retinal illuminance on 11 adult cats, five from nor-
mal control and the rest from IAA treated cats. The cats 
were not treated with any anesthetics, anticholinergic, or 
antispasmodic agents that could dilate pupillary size such as 
atropine. Pupillary area was photographed while cats binoc-
ularly viewed a flash light source that had at 30 lx first then 
1200 lx, respectively. Thus, the shooting distance varied 
between the camera and a moving animal. Consequently, 
the pictured pupil size varied from animal to animal even if 
the photographs were taken under the same luminance lev-
els. To compensate for this error and estimate the captured 
pupillary size objectively, we calculated the relative ratio of 
pupillary area vs. the entire corneal area. This ratio properly 
reflects the pupillary area variation under different intensi-
ties of light illumination. All measurements were made in-
dependently by at least two investigators and checked for 
consistency. To avoid circadian effects on pupillary areas, 
animals were housed at 12 h/12 h light and dark lighting 
environment. All measurements were performed between 
9:00 and 10:00 a.m.. Only animals where PLRs were relia-
bly recorded through the entire protocol were included. Due 
to technical difficulties in the measurement, the failed re-
cordings were not included. Images captured were pro-
cessed with a graphic software (Photoshop CS5, Adobe 
Corp., San Jose, California, USA).  
1.3  Electroretinogram (ERG)    
The full-field (Ganzfeld) ERG was recorded with an electro- 
retinography recording system (RETIport, Roland Consult, 
Brandenburg, Germany). Recordings were performed fol-
lowing the ISCEV standard for full-field clinical electro-
retinography. The ERG recordings were conducted in three 
normal and six IAA treated animals. All animals were as-
sessed with the full-field ERG. Cats were anesthetized using 
the protocol previously described by Nan et al. [15]. During 
the recording, the animal body temperature was maintained 
at 37C with a heating blanket. The eyes were anesthetized 
with 1% tetracaine hydrochloride eye drops. The pupil was 
dilated with topical application of eye drops containing 
0.5% tropicamide and 0.5% phenylephrine (Santen, Japan). 
Animals were dark adapted for 30 min before the scotopic 
ERG recording. The ERG was recorded with an active cor-
neal contact lens electrode (ERG-Jet F-06 Lens, Fabrinalsa, 
Sweden). The reference and ground electrodes were inserted 
subcutaneously at the forehead skin and the tail, respective-
ly. The cornea was kept moist with 0.1% Sodium Hyalu-
ronate eye drops (Santen, Japan). The intensity of white 
light stimulation for scotopic ERG was set at 0.01 cd m2 
first. The intensity was then increased to 3 cd m2. The  
oscillatory potentials were recorded with the same intensity 
(3 cd m2). The cat was then light adapted in a photopic 
background (25 cd m2) for 30 min. The stimulus intensity 
for photopic ERG was 3 cd m2. Each recording was aver-
aged three times at the above luminance levels. The 30 Hz 
flicker stimulation was recorded at the same intensity but 
averaged eight times.  
1.4  Behavioral evaluation 
Three normal and six IAA-treated cats that had no PLR and 
ERG responses were selected for behavioral evaluation un-
der day light conditions. The testing course was 15 m long 
and 1.5 m wide. There were eight barricades in the course. 
The distance between the two barricades was 2 m. Each 
barricade was 1.2 m wide and was placed on the one side 
wall of the course alternatively to form a Z-shaped obstacle 
path. This would allow a 0.8 m space through which cats 
could navigate between the barricade and side wall. Each 
barricade had the option to slide to the left or right side wall 
of the course. The barricade positions were changed ran-
domly between runs to account for learning behavior. Each 
animal was allowed to run three times. During a test, a cat 
was released at the entrance of the course; the transit time 
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was measured from the first forward motion to passing 
through the exit. The time course of animals negotiating 
through the obstacle path and the number of collisions made 
by the cat while negotiating the path were recorded with a 
video camera (Powershot 870, Canon USA, New York).  
1.5  Histological examination  
After the behavioral tests, four cats were sacrificed, two of 
them were normal and the rest were six months after IAA 
treatment, respectively. Both of the IAA-treated cats have 
no pupillary light reflex and ERG responses. The details of 
immunohistochemical staining have been described else-
where [15]. Briefly, eyes were enucleated while animals 
were under deep anesthesia and the lens and vitreous were 
immediately removed with a pair of fine-tip forceps. Then 
eyecups were fixed by a 4% paraformaldehyde in phosphate 
buffer (0.1 mol L1, pH 7.4) for 90 min at room temperature. 
After gradient elution using 10%, 20%, 30% sucrose (pH 
7.4), OCT embedded retinas were froze and cut at a thick-
ness of 10 m. The cryosections were mounted on glass 
slides and allowed to dry overnight. For histochemical ex-
amination, sections were stained using a standard hematox-
ylin-eosin-saffranin staining protocol and viewed with a 
Olympus microscope (Xi-71, Olympus Corp., Japan). Im-
ages of stained retinas were captured with a CCD camera 
(700D; Nikon, Tokyo, Japan) coupled to a desktop computer 
equipped with Photoshop graphic software (CS5 Photoshop, 
Adobe Corp., San Jose, California, USA).  
1.6  Statistical analysis 
Results are reported as mean±SEM. ANOVA and Student’s 
t-test were used for the determination of statistical signifi-
cance among treatment groups. 
2  Results 
IAA induced photoreceptor degeneration resulted temporary 
loss visual function during the first week in all treated ani-
mals. However, some cats gradually regained visual func-
tion during next couple of months or so but others did not 
show any sign of visual guided behavior or visual function. 
Thus we suspect the latter became permanently blind. To 
objectively determine if these animals have any residual 
visual function we performed the following tests six months 
after the IAA treatment.  
2.1  PLR and relative ratio of pupillary area 
Animals were treated with IAA (20 mg kg1) by intravenous 
injection at an ear vein that is running along the outer edge 
towards the tip of the ear. Functional evaluations were per-
formed six months post IAA treatment. Controls were 
age-matched. Figure 1 compares representative PLR re-
sponses between a control (Figure 1B and D) and an IAA 
treated cat (Figure 1A and C) six months post-injection. 
Notice Figure 1C, due to the shooting angle of the camera, 
the widely dilated left pupil was captured. Compared to a 
weak light illumination (30 lx, Figure 1D), the pupillary 
area of control animal was reduced in response to a strong 
flash light illumination (1500 lx, Figure 1B), whereas that 
of IAA treated animal showed a less constricted pupillary 
area (Figure 1A and C). To quantitatively evaluate the pu-
pillary area under these testing conditions, we repeated the 
measurement with normal and IAA treated animals (normal: 
n=5, 10 eyes; IAA: n=4, 8 eyes). As shown in Figure 2, it 
reveals the ratio of relative pupillary area changes before 
and after light stimulation between the control and IAA  
 
 
Figure 1  Photographs of pupillary light reflex (PLR) under different 
illuminance levels in normal and IAA treated cats. A, IAA treated cat PLR 
under 1500 lx light exposure. B, Normal cat PLR under 1500 lx. C, PLR of 
an IAA treated cat under 30 lx illuminance. D, Normal cat PLR under 30 lx. 
 
Figure 2  Histogram comparing averaged pupillary area under light and 
dark conditions in normal and IAA treated cats. Average ratio of pupillary 
area was taken under dark (30 lx) first, then light illumination (1500 lx) 
(mean±STDEV). Under 30 lx illumination, the averaged ratio of pupillary 
area was 0.52±0.09 and 0.61±0.17 for controls and IAA treated animals, 
respectively; under 1500 lx, it was 0.08±0.03 and 0.3±0.11 for controls and 
IAA treated animals, respectively. Vertical coordinate shows the averaged 
ratio of pupillary area and horizontal axis includes normal and IAA treated 
animals tested under two illuminance levels (P<0.01, respectively, 
ANOVA). 
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treated animals (mean±STDEV). The averaged ratio under 
30 lx was 0.52±0.09 and 0.61±0.17 for controls (n=5) and 
IAA treated animals (n=4), respectively. The ratio decreased 
under 1500 lx illumination (controls: 0.08±0.03, n=5; IAA 
treated: 0.3±0.03, n=4). As show in Figure 2, these changes 
were statistically significant for both controls and IAA 
treated cats (t test: normal, P<0.0001; IAA, P<0.0007). 
However, as the comparison was made between the ratios of 
changes in averaged pupillary areas under the two illumi-
nance levels, the magnitude of pupillary area change was 
6.99±2.59 and 2.15±0.35 (P<0.01, t-test), for controls and 
IAA treated animals, respectively.  
2.2  Full-field electroretinogram (ff-ERG) 
Since the reduced PLR response only reflects the animal’s 
light reflex but not retinal visual function. Therefore, we 
performed ERG screen. Figure 3 compares representative 
dark- and light-adapted ff-ERG responses between normal 
and IAA treated animals. Figure 3A plots the mean a- 
(baseline to trough) and b-wave (baseline to peak) responses 
for control (upper left chart) and IAA-treated cats (upper 
right chart) at the stimulus intensity of 0.01 cd m2. As 
shown in the panel, the ff-ERG responses of a normal and 
the IAA-treated cat exhibited completely different response 
patterns. In comparison with the former, the ff-ERG response 
of the latter was completely lost. Figure 3B shows their ERG 
responses to visual stimulation intensity of 3 cd m2. Figure  
 
 
Figure 3  Full-field electroretinogram of normal and IAA treated animals. 
Left column, normal cat; right column, IAA treated cat. A, Scotopic 0.01: 
the animal was dark adapted for 30 min, the intensity of light stimulation 
was 0.01 cd m2, and the vertical coordinate was response amplitude, 250 
V div1. The abscissa is time scale (25 ms div1). a, a-wave; b, b-wave. B, 
Scotopic 3 ERG: the intensity of light stimulus increased to 3 cd m2, the 
amplitude is 500 V div1. C, Photopic 3 ERG: oscillatory potential 100 
V div1. D, Photopic 3 flicker: the animal was light adapted at 25 cd m2 
for 30 min before the visual stimulation, response amplitude 50 V div1. 
3C depicts the oscillatory potentials in response to stimula-
tion intensity of 3 cd m2. Figure 3D compares flicker ERG 
responses of normal and IAA treated animals. Together, 
ERG response profiles under scotopic and photopic stimula-
tion patterns demonstrate that both rod and cone driven in-
puts are completely extinguished after the IAA treatment. 
To quantitatively assess the impact of IAA, the measurements 
were conducted in more control (n=3) and IAA treated ani-
mals (n=6). As shown in Figure 4, ERG a-, b-wave compo-
nents and flicker responses were drastically reduced in IAA 
treated animals. Thus, the present electrophysiological evi-
dence indicates that IAA treatment abolished both rods and 
cones functions.   
2.3  Vision behavioral test 
The ERG result suggests that IAA treatment caused sub-
stantial loss of a and b waves and scotopic and photopic 
retinal functions were substantially eliminated. However, it 
remained to be verified if the IAA treated animal had any 
residual visual functions. To access visual function of IAA 
treated animals, we conducted a visual behavioral test in an 
obstacle-avoidance course. Three normal and six IAA 
treated cats were selected for the test. During the test ani-
mals were placed at one end of the testing course (width, 
1.5 m; length, 15 m), the animal had to avoid obstacles and 
run through the course. The time course of animals moving 
through the obstacle path and the number of barricades 
crashed were recorded. As shown in video clips, compared 
to normal cat (clip A), the IAA treated animal showed a 
completely different running pattern that showed no indica-
tion of using visual organ (clip B). We quantitatively ana-
lyzed this visual behavior pattern, as shown in Figure 5. In 
comparison with controls (7.21±2.55, n=5), IAA treated 
animals spent a significantly long time in the course  
 
 
Figure 4  Histogram comparing averaged amplitudes of D-ERG respons-
es between normal and IAA treated cats. Columns Normal-A and Blind-A, 
comparison of the averaged a-wave between normal (180.67±43.30, n=3) 
and IAA treated cats (3.81±4.77, n=6). Columns Normal-B and Blind-B, 
comparison of the averaged b-wave between normal (571.17±104.88, n=3) 
and IAA treated cats (9.45±5.72, n=6). Column normal-F and Blind-F, 
comparison of flicker ERG between normal (74.9±16.84, n=3) and 
IAA-treated animals (3.4±2.96, n=6). The vertical coordinate depicts the 
averaged amplitudes (µV) and the horizontal axis shows ERG wave com-
ponents. Conventions are as for Figure 3 (P<0.01, respectively, ANOVA). 
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Figure 5  Averaged passing times in normal and IAA treated cats. The 
histogram compares averaged passing times between normal and IAA 
treated animals. The vertical coordinate depicts averaged passing time for 
normal (7.21±2.55) and IAA treated (57.33±4.62) animals (P<0.01, t-test).  
(59.11±2.66, n=6) and always run-off obstacles before  
exiting. Indeed, Figure 5 clearly demonstrates that IAA 
treated animals completely lost visual detection capability 
and were unable to navigate barricades. Together, evidence 
from this experiment confirms the two prior test results and 
reveals that the IAA treated animals completely lost visual 
function. 
2.4  Histochemical examination 
Finally, we evaluated histochemical characteristics of reti-
nal structures in both normal and IAA treated animals. As 
shown in Figure 6, in comparison with normal retina (Fig-
ure 6B), the ONL had virtually disappeared at all locations 
from center to peripheral retina in the IAA treated animal 
(Figure 6A and C–E). It is evident that GCL of the IAA 
treated retina appears spared from the IAA induced damages. 
3  Discussion 
The present study demonstrates that IAA can be used to 
induce a complete elimination of photoreceptors and results 
in thorough abolition of ERG responses. Consequently, be-
havioral test confirms that IAA treated animal entirely lost 
visual function. Together, we present evidence that the IAA 
treatment produced an acute cat model of complete blind-
ness that can be used for evaluation of visual function  
restoration or related experiments. Genetically modified 
feline model of photoreceptor degeneration has been devel-
oped for over the years [16–21]. However, one of the dis-
advantages of these animal models is the slow progress of 
the photoreceptor degeneration. For instance, it could be 
developed over the period of 12–16 months [18,19] or up to 
four years [16,17]. Furthermore, one of the most inevitable 
drawbacks is the unpredictable disease status of the animal 
model. For instance, one could not predict the degree of 
blindness in photoreceptor depleting animals. To the ex-
treme, there is no animal model available for acute complete 
photoreceptor depletion. Thus, the acute and complete pho-
toreceptor degeneration reported here could offer a valuable 
animal model for biological interventions such as gene 
therapy at the end stage of retinal disease.  
The IAA has been extensively used as an effective tool to 
selectively eliminate retinal photoreceptors in a variety of 
species for the last 60 years [1,3,4,10,11,14,22]. As ob-
served in other species, the toxic effects of IAA treatment 
are dose dependent. Noell noted that a single injection of 
the toxin through a limb vein (12 mg kg1) induced acute 
optic nerve potential and ERG amplitude declinations sim-
ultaneously within 90 s after the injection and disappeared 
within the next minute [3]. However, the IAA abolished the 
ERG and other manifestations of the photoreceptor function  
 
 
Figure 6  Sections of normal and IAA-treated feline retinas. A standard hematoxylin-eosin-saffranin protocol stained retinal section extending from the 
optic disc to the periphery of the retina three months after 20 mg kg1 IAA treatment. A, An IAA treated cat retinal section. B, Normal retina section. ONL, 
outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer; RPE, retinal pigment epithelium. CE, Retinal sections from different regions of the 
IAA treated retina (A). ONL had virtually disappeared at all locations from center part to periphery in IAA-treated retina. The remaining retinal layers ap-
peared normal and the INL and GCL are readily discernible. 
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only temporarily. The irreversible effects were produced 
only if the injection was repeated once or twice. Further-
more, it was also reported that, if the dose of a single injec-
tion increased to 22 mg kg1, cats were found blind six 
weeks later and pathological examinations showed almost 
complete loss of outer and inner segments, all outer nuclei 
being pyknotic [4]. Thus higher dose of IAA should be 
pursued if the purpose is to induce complete blindness in 
cats. However, our pilot study showed that the tolerance to 
IAA varied substantially among cats and the dosage over 
the range of 21–25 mg kg1 was lethal if the injection was 
made via a limb vein. Subsequently, Burke and Hayhow also 
made similar observations [23]. Alternatively by delivery 
IAA through an ocular artery, the long posterior ciliary ar-
teries (LPCA) that provide blood supply to both the retina 
and choroid, Berson reported 30%–40% photoreceptors 
depletion with 0.268 mg/0.1 mL of IAA injection while the 
percentage increased to 50% if the dose was doubled (0.52 
mg/0.2 mL) [21]. However, this method is technically chal-
lenging and the dosage of IAA for complete rods and cones 
removal remains to be determined. It was reported that, af-
ter a swine received a single injection of IAA via ear vein 
(20 mg kg1), at two weeks post-IAA there was no rod- or 
cone-driven ERG response [11]. Thus, it is plausible that ear 
vein injection is more effective than limb vessel delivery. 
Indeed, after we adopted this alternative approach the suc-
cessful rate was greatly improved. However, we noted that 
animals temporarily lost visual function during the first 
week of the IAA treatment, but some of them gradually 
regained partial visual functions during several weeks. 
Nevertheless, it was observed that if an animal is blinded 
for more than three months, few regained any visual func-
tions. Thus by using this technique we successfully pro-
duced IAA induced acute blindness in cats.  
A considerable drawback of high dosage IAA treatment 
is the adverse effects of the toxin on animals. It was report-
ed that malate could protect the life of an experimental ani-
mal by providing it with some suitable energy-producing 
intermediate which could bypass the iodoacetate block 
without affecting glycolysis. Indeed, it was demonstrated in 
rats [2]. Unfortunately, we tried this approach on four cats 
but failed. It could be a species difference. However, com-
pensating for the adverse effects of IAA should be a subject 
of future investigation.
It was observed in the present experiment that complete 
elimination of photoreceptors did not result in complete 
abolition of PLR. It is expected because light signal is 
sensed by two different types of photoreceptors, the con-
ventional photoreceptors and intrinsically photosensitive 
retinal ganglion cells or melanopsin expressing retinal gan-
glion cells (ipRGCs), and the latter is much less sensitive 
than conventional photoreceptors [25]. Although there is 
substantial evidence that both conventional photoreceptors 
and ipRGCs contribute to PLR, depleting ipRGCs could 
substantially diminish PLR [25–27]. Since there is no mel-
anopsin antibody available that specifically targets ipRGCs 
in the cat, we cannot evaluate the impact of IAA on ipRGCs 
in the cats. Nevertheless, the present result reveals that 
complete removal of conventional photoreceptors substan-
tially reduced but did not completely abolish PLR. Thus our 
result is in agreement with previous reports [25–27] and 
suggests that the residual PLR could be contributed by sur-
viving ipRGCs. 
We performed behavioral test to determine if the animals 
had any residual visual functions. As shown in Figure 5, the 
blinded cats showed significantly slower passing time than 
the controls. However, the behavioral activity patterns var-
ied among the blinded animals. We realized that one cannot 
identify a blinded animal only relying on number of obsta-
cles the animal run-off during the test. For instance, one 
blind cat did not knock over any obstacles but the activity 
pattern of the animal showed that it did not visually identify 
any of those obstacles but sensed the objects with its whisk-
ers or other body parts such as paws. On the other hand, one 
cannot judge if an animal is blind by solely relying on the 
passing time. We encountered one of the blinded animals 
that had short running time as controls but it knocked over all 
obstacles on the way to the end of the test course. The animal 
was calm during the test and its behavioral pattern showed 
that it did not recognize any of the obstacles before bumping 
into it. Thus, we did not include this animal’s running time in 
Figure 5.  
In conlusion, high dose IAA application (20 mg kg1) via 
ear vein injection created an acute and reliable complete 
photoreceptor degeneration model in the cat. This model 
can be applied to genetic and cellular therapies for visual 
function restoration. 
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